Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Zink

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|June 1, 1994
Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapyA K Chakraborty, M A Zink, C P Hodgson
Biochemical and Biophysical Research Communications|April 17, 1995
Expression of VL30 vectors in human cells that are targets for gene therapyA K Chakraborty, M A Zink, C P Hodgson
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1997
Biosynthetic retrovectoring systems for gene therapyC P Hodgson, G Xu, F Solaiman, et al.
Cancer Gene Therapy|March 4, 2000
Fusogenic effects of murine retroviruses and cationic enhancers of transductionG Xu, F Solaiman, M A Zink, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1993
Synthetic retrotransposon vectors for gene therapyA K Chakraborty, M A Zink, B M Boman, et al.
Molecular Reproduction and Development|May 29, 2000
Modular retro-vectors for transgenic and therapeutic useF Solaiman, M A Zink, G Xu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|June 1, 1994
Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapyA K Chakraborty, M A Zink, C P Hodgson
Biochemical and Biophysical Research Communications|April 17, 1995
Expression of VL30 vectors in human cells that are targets for gene therapyA K Chakraborty, M A Zink, C P Hodgson
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1997
Biosynthetic retrovectoring systems for gene therapyC P Hodgson, G Xu, F Solaiman, et al.
Cancer Gene Therapy|March 4, 2000
Fusogenic effects of murine retroviruses and cationic enhancers of transductionG Xu, F Solaiman, M A Zink, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1993
Synthetic retrotransposon vectors for gene therapyA K Chakraborty, M A Zink, B M Boman, et al.
Molecular Reproduction and Development|May 29, 2000
Modular retro-vectors for transgenic and therapeutic useF Solaiman, M A Zink, G Xu, et al.
Pageof 1